content top

Safety and Efficacy of Intravitreal Preservative-free Triamcinolone for ME Secondary to Diabetes or Retinal Vein Occlusion

Purpose: To evaluate the efficacy and safety of preservative-free triamcinolone acetonide injectable suspension (Taioftal) for the treatment of macular edema secondary to diabetes or retinal vein occlusion. Design, Setting & Participants: From January 2015 to December 2015, at Ospedale Maggiore of Bologna, a retrospective study was conducted on patients suffering from macular edema secondary to diabetes or retinal vein occlusion....

Read More

Central Retinal Vein Occlusion: What`s New ?

Despite numerous studies describing predominantly its clinical course, many aspects of central retinal vein occlusion (CRVO) remain unclear. Hypotheses on the pathogenesis of CSCR have ranged from a basic alteration in the blood stream to an involvement of the blood vessel wall. We reviewed the different therapeutic approaches, including laser induced chorioretinal anastomosis (LICRA), vitrectomy (PPV) and intravitreal treatment (IVT)....

Read More

Dexamethasone Implant in a Pregnant Woman for the Treatment of ME in CRVO

Poster Jesus Zarallo Gallardo Introduction: There are several retinal diseases that may worsen or alter during pregnancy as a result of hematologic, hormonal, metabolic, cardiovascular, and immunologic changes. Although normal pregnancy and its hypercoagulable state may induce retinal vein occlusion, hereditary or acquired changes in hemostatic factors increase the risk of thromboembolic events. The risk of venous thromboembolism in...

Read More

Surgery Associated with Intravitreal Anti-VEGF Agents in CRVO. A More Rational Approach?

Central retinal vein occlusion is a multi-factorial event. Like any venous thrombosis, one of the key components in play is stenosis of the vessel. In the eye, this stenosis generally originates from the vein being compressed by a sclerotic artery in a non-expandable space such as the optic nerve at the level of lamina cribrosa. Resection of the lamina cribrosa should therefore result in proper reperfusion of the central retinal vein and...

Read More

3 Bevacizumab vs 2 Triamcinolone Injections in Recent CRVO

Advantages: Repeated intravitreal injections of bevacizumab (IVB) are more efficacious than repeated intravitreal injections of triamcinolone (IVT) in the treatment of macular edema in eyes with acute central retinal vein occlusion (CRVO). Methods: In a randomized clinical trial, 110 eyes with recent onset (less than 12 weeks) CRVO were included. Participants were randomly assigned to two treatment groups: IVB group (56 eyes), patients...

Read More

Ischemic Changes After Intravitreal Injections for Treatment of ME with CRVO

Advantages: To investigate the ischemic changes after intravitreal injection for treatment of ME with CRVO. Methods:   55 patients treated with anti-VEGF for ME with CRVO were included. Take home message: Intravitreal injection for ME with CRVO could induce ischemic changes in some cases. So these possibilities have to be notified to patients and close follow-up is...

Read More
content top